Single-centre Experience of Patients with Metastatic Urothelial Cancer Treated with Chemotherapy Following Immune Checkpoint Inhibition (European Urology Oncology)
Chemotherapy and immune checkpoint inhibition can be sequenced in metastatic urothelial carcinoma even after previous chemotherapy exposure. Patients can be safely treated with further chemotherapy. However, the positive effects of chemotherapy will not be durable in the majority of patients.